Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure–Response Relationships in Renal Transplant Patients
Kanecia O. Zimmerman(Duke University), Michael Cohen‐Wolkowiez(Duke University), Jeffrey T. Guptill(Duke University), Chiara Melloni, Kevin D. Hill(Duke University), Rachel G. Greenberg(Duke University), Daniel González(University of North Carolina at Chapel Hill), Lawrence Ku(Center for Drug Evaluation and Research), Uptal D. Patel(Medical University of Vienna), Christoph P. Hornik(Duke University), Nan Zheng(Capital Medical University), Wenlei Jiang(United States Food and Drug Administration), Huali Wu(Duke University)
Cited by 13
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers
|Nature Communications|2018|296